Total parathyroidectomy reduces elevated circulating fibroblast growth factor 23 in advanced secondary hyperparathyroidism
Total parathyroidectomy reduces elevated circulating fibroblast growth factor 23 in advanced secondary hyperparathyroidism
复制标题
DOI:
10.1053/j.ajkd.2004.05.026
复制
发表时间:
2004-09-01
影响因子:
13.2
通讯作者:
Fukagawa, M
中科院分区:
文献类型:
--
作者:
Sato, T;Tominaga, Y;Fukagawa, M
Background: Secondary hyperparathyroidism is a common complication inpatients with stage 5 chronic kidney disease (CKD), accelerated by hyperphosphatemia. Fibroblast growth factor 23 (FGF-23), a phosphorus-regulating protein, has key roles in several phosphate-wasting disorders. The aim of this study is to examine the association of advanced secondary hyperparathyroidism with circulating FGF-23 levels. Methods: Fifteen patients with marked secondary hyperparathyroidism (parathyroid hormone [PTH], 990+/-118 pg/mL [ng/L]) were enrolled. All underwent parathyroidectomy with forearm autotransplantation (PTX), and their FGF-23 levels were measured before and after PTX (days 1, 3, 7, and 10) by means of sandwich enzyme-linked immunosorbent assay. Results Preoperative FGF-23 levels correlated positively with phosphorus (P